Cell sorting

Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects

Retrieved on: 
Wednesday, November 23, 2022
Cell sorting, COVID-19, Autoimmunity, Degenerative disease, Single cell, Immunomodulation, Inflammation, Perforin, CD8, CD3, RNA, Harvard Medical School, Safety, Brigham and Women's Hospital, Patient, Pharmacist, FACS, Cytokine, EBV, Granzyme, BWH, CNS, Mab, Cytokine release syndrome, Research, Neutralizing antibody, IV, Human, Animal, Crohn's disease, Immunotherapy, Frontiers, Vaccine, Pharmaceutical industry, Regulatory T cell, Brigham, MD, Foralumab, Immunology

The findings support Tizianas intranasal foralumab platform as a new modality for the treatment of autoimmune and CNS diseases.

Key Points: 
  • The findings support Tizianas intranasal foralumab platform as a new modality for the treatment of autoimmune and CNS diseases.
  • This is likely due to the partial signaling that occurs at intermediate doses which favors the induction of regulatory cells.
  • When intranasal foralumab was dosed in humans at the above levels, immunological activity and a favorable safety profile were observed.
  • This article provides a wealth of scientifically rigorous immunologic data on intranasal foralumab, said Matthew Davis, MD, RPh, Chief Medical Officer of Tiziana.

Insights on the Cell Sorting Global Market to 2027 - 46 Players Featured Include Affymetrix, Beckman Coulter and Union Biometrica Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 10, 2021
Biotechnology, Genetics, Health, CAGR, Cell sorting, Growth, COVID-19, Magnetic-activated cell sorting, Cell, Pet

The "Cell Sorting - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Sorting - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Fluorescence-based Droplet Cell Sorting, one of the segments analyzed in the report, is projected to record a 4.8% CAGR and reach US$126.4 Billion by the end of the analysis period.
  • In the global MEMS-Microfluidics segment, USA, Canada, Japan, China and Europe will drive the 7% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$35.3 Billion by the year 2027.

Outlook on the Cell Sorting Global Market to 2026 - Featuring Bio-Rad Laboratories, Union Biometrica and Bulldog Bio Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 9, 2021
Health, General Health, Mortality, Population, Adoption, Cancer, Infection, Method, Cell sorting, HIV, Disease, Growth, Organic, Research, Degenerative disease, Woman, Incidence, Therapy, Center, Diagnosis, FACS, Time, Conditional sentence, Cell, Patient, Life, Prevalence, Man, Vaccine, Pharmaceutical industry

The gold standard technology for this purpose is fluorescence-activated cell sorting (FACS).

Key Points: 
  • The gold standard technology for this purpose is fluorescence-activated cell sorting (FACS).
  • FACS is thus anticipated to be the segment driving the growth of the Cell Sorting market during the forecast period owing to its accuracy and increasing applications.
  • The Cell Sorting market growth in these regions can be attributed to advanced research infrastructures, significant health care spending, and increase government funding for research.
  • The increase in the funding and the rising prevalence of chronic diseases boost the market growth in the region.

NanoCellect Biomedical Reinvents the Cell Sorter with the WOLF G2

Retrieved on: 
Thursday, May 13, 2021
Industrial machinery, Sorter, Cell sorting

b'SAN DIEGO, May 13, 2021 /PRNewswire/ --NanoCellect Biomedical, a leader in the development of cell sorting, announces the virtual launch , scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect\'s family of products.

Key Points: 
  • b'SAN DIEGO, May 13, 2021 /PRNewswire/ --NanoCellect Biomedical, a leader in the development of cell sorting, announces the virtual launch , scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect\'s family of products.
  • The WOLF G2 features simple and sterile cell sorting.
  • "The WOLF G2 Cell Sorter will help to accelerate the adoption of cell sorting and enable individual labs, core labs, startups, and large biopharma to perform high-intensity, single-cell applications using our industry-leading cell sorting technology.
  • "\nThe original WOLF Cell Sorter has grown in popularity because of its small footprint, easily fitting on a laboratory benchtop or inside a tissue culture hood.

Factorial Diagnostics, IncellDx Sign Exclusive License for Novel in situ Library Prep for Subsequent Next Generation DNA Sequencing

Retrieved on: 
Thursday, August 6, 2020
Branches of biology, Biotechnology, Biology, Life sciences, Molecular diagnostics, Microfluidics, Cell sorting, Single cell sequencing, Single-cell analysis

The San Carlos based start-up, is utilizing IncellDX's new reagent, IncellMax-Seq, to performin situlibrary preparation for Next Generation Sequencing (NGS) applications.

Key Points: 
  • The San Carlos based start-up, is utilizing IncellDX's new reagent, IncellMax-Seq, to performin situlibrary preparation for Next Generation Sequencing (NGS) applications.
  • Factorial's proprietary front-end technology will be compatible with a number of cell isolation strategies, including fluorescence-activated and microfluidic cell sorting.
  • John Wells, CEO and co-founder of Factorial Diagnostics, commented, "Current bulk, NGS-based cancer diagnostic tests are losing valuable phenotypic information during library prep.
  • IncellDx, Inc., located in San Carlos, California, is a molecular diagnostics company dedicated to revolutionizing healthcare, one cell at a time.

Hitachi and ThinkCyte announce collaboration to develop an AI-driven cell analysis and sorting system

Retrieved on: 
Wednesday, July 1, 2020
Branches of biology, Biology, Natural sciences, Cell biology, Laboratory techniques, Cells, Analytical chemistry, Biochemistry, Single-cell analysis, Cell sorting, Hitachi, Single cell sequencing

TOKYO, July 1, 2020 /PRNewswire/ --Hitachi, Ltd. (TSE: 6501, "Hitachi") and ThinkCyte, Inc. ("ThinkCyte") today announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system.

Key Points: 
  • TOKYO, July 1, 2020 /PRNewswire/ --Hitachi, Ltd. (TSE: 6501, "Hitachi") and ThinkCyte, Inc. ("ThinkCyte") today announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system.
  • ThinkCyte has been performing research and development focused on high-throughput single cell analysis and sorting technology to precisely analyze and isolate target cells.
  • While such single cell analysis and sorting technologies are vital to life science and medical research, it has been thought impossible to achieve high-throughput cell sorting based on high-content image information of every single cell.
  • Hitachi and ThinkCyte have initiated a joint development of the AI-driven cell analysis and sorting system based on their respective technologies, expertise, and know-how.

Akadeum & NanoCellect Collaborating to Improve Rare-Cell Workflows and Results

Retrieved on: 
Wednesday, June 10, 2020
Branches of biology, Biology, Life sciences, Biotechnology, DNA sequencing, Cell sorting, Cells, Single cell sequencing, Antibody

From single cell genomics to antibody discovery, researchers increasingly require more efficient, rapid, and gentle workflows to advance cellular research applications.

Key Points: 
  • From single cell genomics to antibody discovery, researchers increasingly require more efficient, rapid, and gentle workflows to advance cellular research applications.
  • Use of the two gentle and high purity processes of floatation-based cell isolation ahead of single-cell sorting and plating can significantly improve these workflows.
  • NanoCellect and Akadeum are combining the strengths of their core products and technologies to provide customers improved cell isolation, analysis, gentleness, and rare-cell sorting efficiency to single-cell workflows.
  • "Akadeum is thrilled to provide the desired gentle and effective cell isolation ahead of WOLF cell sorting," said Michael Maloney, Director of Marketing & Business Development at Akadeum.

Global Cell Sorting Market 2019-2023 | Growing Applications in Cancer Research to Boost Growth | Technavio

Retrieved on: 
Monday, June 1, 2020
Biotechnology, Health, Oncology, Stem cells, Branches of biology, Articles, Biology, Benchmarking, Strategic management, Marketing strategy, Cell sorting, Market research, Becton Dickinson, Marketplace, Bio-Rad Laboratories

Our cell sorting market report covers the following areas:

Key Points: 
  • Our cell sorting market report covers the following areas:
    This study identifies technological advances as one of the prime reasons driving the cell sorting market growth during the next few years.
  • We provide a detailed analysis of around 25 vendors operating in the Cell Sorting Market, including some of the vendors such as Becton, Dickinson, and Co., Bio-Rad Laboratories Inc., Cytonome/St.
  • Backed with competitive intelligence and benchmarking, our research reports on the Cell Sorting Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

Fluxion Launches BioFlux One, the Affordable System for Cellular Interaction Assays Under Physiological Flow

Retrieved on: 
Wednesday, March 18, 2020
Natural sciences, Branches of biology, Articles, Microfluidics, Biotechnology, Nanotechnology, Laboratory techniques, Assay, Organ-on-a-chip, Cell sorting

The BioFlux One system is the solution for labs that run flow cell experiments but don't need 2-phase flow.

Key Points: 
  • The BioFlux One system is the solution for labs that run flow cell experiments but don't need 2-phase flow.
  • It provides all the benefits of the industry standard BioFlux system, but at a price point similar to a "home brew" flow cell setup.
  • The BioFlux system is the established standard for a wide range of cellular interaction assays under physiological flow.
  • The heart of the BioFlux One system is identical to the BioFlux 200 and the BioFlux 1000z systems: automated control of flow cell experiments with Fluxions unique microfluidic flow cell well plates.

Akadeum Launches Mouse Naïve Cell Isolation Products

Retrieved on: 
Wednesday, March 11, 2020
Branches of biology, Medical specialties, Cell biology, Immunology, Cells, T cells, CD4, Glycoproteins, Cell sorting, Cell isolation, T helper cell

ANN ARBOR, Mich., March 11, 2020 /PRNewswire/ -- Akadeum Life Sciences, Inc., an Ann Arbor-based biotech company, announced today the expansion of its product line with mouse nave CD4+ T cell and mouse nave T cell negative selection isolation kits.

Key Points: 
  • ANN ARBOR, Mich., March 11, 2020 /PRNewswire/ -- Akadeum Life Sciences, Inc., an Ann Arbor-based biotech company, announced today the expansion of its product line with mouse nave CD4+ T cell and mouse nave T cell negative selection isolation kits.
  • The two new kits add to a portfolio of products that leverage Akadeum's proprietary buoyancy-based cell isolation delivering high performance with simpler workflows.
  • Its buoyancy-activated cell sorting (BACS) microbubble kits negatively select for nave T cells and nave CD4+ T cells, resulting in high purity populations untouched and ready for downstream applications.
  • Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached.